07-10, 16:40–17:25 (Europe/Prague), Forum Hall
Have you ever wondered why we are the way we are? Why some individuals develop diseases while others remain healthy? And what does Python have to do with all of this? Join this talk in which we will explore the interface between biology, technology and medicine, in the context of the research of rare genetic diseases. Learn what the Moore’s law has to do with advances in genetics and medicine, or why bigger is not always better.
Beginner
Anna is a bioinformatics scientist focused on genome analysis techniques and their applications in understanding rare genetic diseases. She received the Bolzano Award for her doctoral thesis.
She holds a PhD in Molecular and Cell Biology, Genetics, and Virology and two MSc degrees: one in Medical Technology and Informatics, and the other in Molecular Biology and Genetics, all from Charles University.
Anna has co-authored over 25 publications in peer-reviewed journals and has presented her work at various scientific conferences.
Currently, she works as a Senior Bioinformatics Scientist at DNAnexus company, where she assists customers with their bioinformatics analysis. She also conducts research at the Research Unit for Rare Diseases at the First Faculty of Medicine, Charles University.